Tag: medical therapeutics
-
Proteios Technology, Inc. Awarded $1.6 Million NIH SBIR Grant to Commercialize its Multivariate Cell Isolation Technology
SEATTLE, Wash. — Proteios Technology, Inc. is pleased to announce it’s received a $1.6 million SBIR Phase II grant from the National Institutes of Health (NIH) to commercialize its multivariate (parallel) cell isolation technology. Grant funds will be used to extend Proteios’ cell isolation kits to include up to 20 of the most common cell…
-
End-to-end transport Solution for Medical therapies and Products Relying on Cold Chain: Secure, Traceable, Reusable
LOS ANGELES, Calif. — Southern California based Mergers and Acquisitions firm ProNova Partners has been commissioned to facilitate investment in or the sale of a patented, groundbreaking packaging technology. The technology facilitates a secure, traceable, and reusable end-to-end transport solution for expensive medical therapies and products that rely on the cold chain.